Mission
TB ALLIANCE IS A NOT-FOR-PROFIT ORGANIZATION DEDICATED TO THE DISCOVERY, DEVELOPMENT AND DELIVERY OF BETTER, FASTER-ACTING AND AFFORDABLE TUBERCULOSIS DRUGS THAT ARE AVAILABLE TO THOSE WHO NEED THEM.
Public Charity
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC is a nonprofit organization categorized as Public Charity based in NEW YORK, NY. Its most recent IRS filing (2024) reports revenue of $63.7M, expenses of $61.5M, total assets of $204.3M. Imperigo tracks 4 reported grant relationships connected to this organization totaling approximately $1.5M.
EIN: 134128413
NEW YORK, NY
Specifically Named Diseases Research
NTEE: H80
Latest filing: 2024
Total Revenue$63.7M
Total Expenses$61.5M
Total Assets$204.3M
Grant Records4
Funding Total$1.5M
Filing Years2019–2024
Where $100 goes at Global Alliance for Tb Drug Development Inc
How Global Alliance for Tb Drug Development Inc divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$90
Programs
the work itself
$8
Management
running the organization
$2
Fundraising
raising the next dollar
Inside the $90 for programs
$79
Research and development
$9
Public affairs and policy
$2
Business development
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
FOR RECIPIENT'S EXEMPT PURPOSE
$8,000
INTERNATIONAL
$19,232
PUBLIC, SOCIETAL BENEFIT
$1,500,000
SUB-AWARD
$8,120
Showing up to 5 of 4 total records — full history available with membership.
Officers & Directors
DIRECTOR (AS OF 12/01/24)
Akshay Vaishnaw
TREASURER/CFO
Angela Vanderploeg
DIRECTOR (AS OF 09/01/24)
Ann Taylor
VICE-CHAIR
Ariel Pablos-Mendez
SECRETARY/CAO
Colleen Pero
CHAIR
David Norton
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $63.7M | $61.5M | $204.3M |
| 2023 | $60.2M | $55.4M | $197.3M |
| 2022 | $56.2M | $55.8M | $176.7M |
| 2020 | $61.3M | $61.7M | $191.2M |
| 2019 | $174.9M | $69.5M | $189.4M |
Between 2019 and 2024, reported annual revenue declined from $174.9M to $63.7M (-64%), with total assets most recently reported at $204.3M.
Interactive year-over-year charts and full filing details available with membership.